甲壳胺─聚氨酯复合膜的界面粘合研究

测定了甲壳胺─聚氨酯复合膜的静态和动态力学性能，并根据两单组分膜和复合膜的应力－应变行为判断复合膜界面粘合的牢固性。讨论了聚氨酯多孔膜与甲壳胺膜，以及聚氨酯预聚体与甲壳胺膜的粘合机理，并从动态力学性能的测试结果得以证实。     

甲壳胺药膜的控制释放研究

以阿司匹林为模型药物研究了小分子药物在甲壳腹膜中的释放行为，结果表明释放是扩散控制的，与膜厚、介质pH值，膜交联度及膜分散性密切相关。改变这些参数可达到比较恒定的延长释放和不同的给药途径。     

聚酯酸酐的合成及其药物释放性能研究

将对羟乙氧基苯甲酸分别与已二酰氯、癸二酰氯和对苯二甲酰氯反应,制备了含酯键的二羧酸.经熔融缩聚,合成了主链含酯键的新型聚酯酸酐.通过¹H NMR、IR及元素分析对单体及聚酯酸酐的结构进行了表征.研究了聚酯酸酐的体外降解和药物释放性能,其降解速率和释药速率次序为:聚4,4'-(已二酰氧二乙氧基)双对苯二甲酸＞聚4,4'-(癸二酰氧二乙氧基)双对苯二甲酸＞聚4,4'-(对苯二甲酰氧二乙氧基)双对苯二甲酸.     

锌与甲壳胺络合物的制备

甲壳胺是甲壳素（2-乙酰氨基-1，4-个葡聚糖）脱乙酰基后的产物，学名为2-氨基－l．4-个葡聚糖，目前主要从虾、蟹壳中提取．这的用途很广，涉及诸多领域［1］．甲壳胺有杀菌、抑菌、消炎、促进伤口愈合的功能，有降低胆固醇，增强免疫力，体内排毒，防治胃溃疡和胃酸过多等功能，它对人体细胞无毒，且有亲和性，不与体液反应，也无抗原抗体反应，国内外已有许多报道[2]．本文报道克服甲壳胺只能溶于弱酸溶液的缺点，将其氧化降解成水溶性低聚物后，作为锌的配体，探讨二者络合的条件及所形成络合物的一些性质，以期能为人体补锌提供新的途…     

油茶皂苷缓释片的制备及其释放度

以羟丙基甲基纤维素和乙基纤维素为骨架材料,乳糖为致孔剂,采用50%乙醇湿法制备了油茶皂苷缓释片.经智能溶出仪与UV测定,油茶皂苷缓释片B的缓释效果良好.     

层状MoS2复合膜的制备及其纳滤与光热抗菌性能研究

二维纳米片构建的层状纳滤膜在工业染料和含盐废水的净化处理中显示出广泛的应用前景,但纳米片间松散的层状结构会影响过滤通道的稳定性,导致对盐类的截留效果不理想.本文以均苯三甲酰氯(TMC)交联单宁酸(TA)官能化的二硫化钼(MoS_2)纳米片构建薄层复合纳滤膜,以解决二维材料构建层状纳滤膜的常见问题.所制备的纳滤膜不仅对荷负电染料(伊文思蓝,分子量960.8)有很高的截留率(98.5%),也能很好地选择性分离染料-盐混合溶液(NaCl截留率15%).同时,该膜还能在严苛环境中保持优秀的稳定性.此外,在近红外光照射下,MoS2纳米片显著的光热转换效应赋予薄层复合纳滤膜一定的抗菌能力,使得该膜在实际应用中具有巨大潜力.     

新型介孔羟基磷灰石/壳聚糖-万古霉素药物释放系统复合材料的制备及体外抗菌和成骨能力

采用冷冻干燥法合成了介孔羟基磷灰石(HA)/壳聚糖(CS)-万古霉素(VCM)药物释放系统复合材料, 利用SEM, XRD和FTIR等方法对材料进行了表征. 结果证实CS与HA混合复合材料具有良好的孔径和孔隙率, 万古霉素吸附于复合材料的表面和内部. 细胞毒性实验[噻唑蓝(MTT)比色法]结果表明, 材料可以促进成骨细胞增殖且具有良好的细胞相容性. 体外抑菌实验结果证实此材料可长时间抑制耐甲氧西林金葡菌(MRSA)的生长, 具有良好的抑菌和杀菌能力. 细胞黏附实验结果表明, 成骨细胞附着于材料表面增殖并通过孔道延伸. 实时聚合酶链式反应(RT-PCR)实验结果表明, 在成骨相关标志产物胶原蛋白-1(COL-1)及骨形态发生蛋白-2(BMP-2)基因上均有较高的表达, 表明材料在体外可以促进成骨细胞生长, 具有良好的成骨能力.     

侧链含5-氟尿嘧啶甲壳胺的合成及其抗肿瘤活性的研究

本文报道了以不同分子量的甲壳胺为载体,制备了侧链含5-氟尿嘧啶的一系列高分子载体药物;通过定氮分析测定了H_2N-基的反应率;由IR、UV和~(13)C-NMR确定了载体药物的结构;模拟生理条件考查了在不同pH的缓冲溶液中5-氟脲嘧啶或其衍生物的水解释放率。体外初步实验结果表明,具有Ⅰ和Ⅱ结构的载体药物对艾氏腹水癌细胞有较强的杀伤作用。     

LiCl／DMAc溶剂体系中长链脂肪酸纤维素酯的制备及其药物释放性能

在ＬｉＣｌ／ＤＭＡｃ溶剂体系中由纤维素与长链脂肪酸氯反应制备长链脂肪酸纤维素酯，并研究了反应条件对酯化反应取代度的影响。结果表明在适当的反应条件下，酯化聚代度可达到２．８５（９５％）。还研究了纤维酯作为药物控制释放载体对ＬＮＧ、Ａｓｐｉｒｉｎ、ＢＡＳ的释放性能。     

磁性壳聚糖微球的制备、表征及其靶向给药研究

磁性微球;阿司匹林;磁性壳聚糖微球的制备、表征及其靶向给药研究     

壳聚糖膜对水杨酸吸附及释放过程的实时介电谱法研究

制备了壳聚糖膜,并且测量了壳聚糖膜/水杨酸溶液、含水杨酸的壳聚糖膜/蒸馏水两个膜/液体系的介电谱,在100～700 kHz频率范围,发现两种体系都存在显著的介电弛豫现象,而且该弛豫的特征参数随壳聚糖膜在相应溶液相中浸泡时间的不同而变化.将该体系介电模型化、并利用在Maxwell-Wagner界面极化理论上建立的公式对介电谱进行解析,得到了体系中两相--壳聚糖膜相和溶液相的介电常数和电导率随时间的变化曲线.通过分析电导变化曲线得知,壳聚糖膜对溶液中的水杨酸有吸附现象,而含有水杨酸的壳聚糖膜在蒸馏水中可以缓慢释放出水杨酸;吸附过程包含的机制有氢键的形成、疏水力和扩散;而水杨酸的脱附过程则包含吸附过程几种机制的逆反应.理论分析和解析结果都验证了介电谱方法对吸附和释放过程实时监测的有效性.     

壳聚糖-g-聚甲基丙烯酸凝胶粒的制备及其药物释放行为

以壳聚糖和甲基丙烯酸为原料,硝酸铈铵为引发剂,合成了不同接枝率的壳聚糖-g-聚甲基丙烯酸(CS-g-PMAA),用FTIR、1H NMR和元素分析表征了产物的结构,以柠檬酸三钠和戊二醛为交联剂制备了具有核壳结构的CS-g-PMAA载药体系。 用UV/Vis检测了CS-g-PMAA粒子对模型药物的释放行为。 结果表明,CS-g-PMAA接枝率为12.21%时药物释放速率最慢,其在pH=1.8介质中药物累积释放量(11 h)为44.18%,而壳聚糖粒子的累积释放量高达65.24%,即接枝改性壳聚糖粒子对药物的缓慢控制释放性能较好; CS-g-PMAA粒子的释药行为还依赖于介质的pH值和盐浓度,在低pH值和低盐浓度下,药物释放速率较快;酶环境下由于载体材料的降解使药物释放速率加快。 分析了不同条件下CS-g-PMAA载药粒子中药物的释放机理。     

Radiation Synthesis of Superabsorbent Hydrogels Based on Chitosan and Acrylic Acid for Controlled Drug Release

Superabsorbent hydrogels based on the natural polymer chitosan and acrylic acid (CS/AAc) was prepared using ⁶⁰Co gamma radiation as a source of initiation and crosslinking. The factors, which affect the preparation of CS/AAc hydrogels such as irradiation dose, CS/AAc ratios, and acrylic acid monomer concentrations, to get the best optimum conditions, were investigated. The kinetic studies of the swelling of CS/AAc hydrogel showed that it follows a Fickian type of water diffusion. The Fickian constant value ‘n’ was more than 0.5 with a high swelling capacity of 300 g/g as superabsorbent hydrogel. In addition, the suitability of CS/AAc hydrogel as carrier material for the drug Chlortetracycline-HCl has been investigated by adsorption isotherm studies. The performance of drug release from hydrogel systems, influenced by acrylic acid ratio and the effect of pH of the medium was studied.     

pH-Dependent Release from Monoolein Cubic Phase Containing Hydrophobically Modified Chitosan

Monoolein (MO) cubic phase incorporating hydrophobically modified chosan (Hm chitosan) was prepared to obtain a pH-dependent release. Following calorimetric study, Hm chitosan had little effect on the crystal structure of MO cubic phase under acidic condition where Hm chitosan is readily soluble. At a higher pH (e.g., pH 9.0), however, the crystal structure of MO cubic phase was disturbed, possibly due to the insolubilization of Hm chitosan at the alkali condition. Whether the dye included in the cubic phase is anionic (amaranth) or cationic (methylene blue), the release from the cubic phase was suppressed as the pH of release medium increased. The structural change of cubic phase caused by the insolubilization of Hm chitosan, or the blockage of the water channel of the cubic phase by precipitated Hm chitosan would be responsible for the suppressed released.     

新型羧甲基壳聚糖水凝胶流变性能,药物释放及细胞相容性研究

羧甲基壳聚糖含有丰富的羧基和氨基, 通过1-乙基-(3-二甲基氨基丙基)碳二亚胺盐酸盐(EDC)和N-羟基琥珀酰亚胺(NHS)共催化交联羧甲基壳聚糖形成新型水凝胶. 调节EDC/NHS用量, 制备不同交联度的羧甲基壳聚糖水凝胶(CMCS hydrogels). 研究水凝胶的流变行为, 结果表明, 高交联度的水凝胶具有较好的弹性形变能力, 较高的储存模量, 这是因为随着交联度的升高, 羧甲基壳聚糖水凝胶化学交联网络结构趋于完善. 以胸腺五肽(TP-5)为模型药物, 初步评价CMCS水凝胶药物释放行为, 结果表明水凝胶交联度越高, 胸腺五肽释放速度越慢. MTT法初步评价了水凝胶细胞毒性, 细胞形态和细胞相对增值速率, 结果表明水凝胶毒性很低. 由此可见, 水凝胶具有良好的生物相容性, 在药物缓释和组织工程领域具有广阔的应用前景.     

Drug Release Study of Systems Containing the Tragacanth and Collagen Composite: Release Characterization and Viscoelastic Measurements

The kinetics of water penetration and pentoxifilline release from both Tragacanth gum and Tragacanth/Collagen matrices has been examined in pure deionised water. The rheological oscillatory measurements of their gel layer obtained by swelling of the imprinted pentoxifilline-filled polymer matrix with water have been performed. To qualify a polymer for application in drug formulation, appropriate gel stiffness is required. The aqueous solution of Tragacanth does not seem to acquire the actual strength that a hydrogel must retain for this purpose. Thus, along with Tragacanth, gelatin, CaCl₂ and 1, 8 octandiamine curing agent were individually blended in a mixture with Tragacanth gum to improve the gel behavior and drug delivery of the system. The strength of the gel at the body temperature (37 °C) was studied using a cone and plate rheometer. It was found that gelatin could enhance the gel strength of Tragacanth by forming a porous composite. The drug release to an aqueous solution at room temperature was analyzed to be slower for a composite of 1:2 Tragacanth/Collagen.     

壳聚糖─海藻酸钠微囊对蛋白质控制释放的研究

采用乳化法制备了可注射用壳聚糖海藻酸钠微囊, 其粒径小于２００ μｍ ,且具有相对较窄的近似高斯分布。牛血清白蛋白作为模型药物在微囊中的包埋率可超过５０ ％ 。通过壳聚糖在海藻酸钠微囊表面的复合,牛血清白蛋白从微囊中的持续释放时间从几个小时延长到半个月以上。     

Preparation and Characterization of Simvastatin-Loaded PCL/PEG Nanofiber Membranes for Drug Sustained Release

Simvastatin (SIM) particles are liposoluble drugs with large particle sizes, resulting in poor compatibility with electrospun polycaprolactone (PCL)/polyethylene glycol (PEG) nanofibers, so that part of them will be exposed to the electrospun nanofiber surface, which is easy to cause the burst release of drugs. Therefore, in this paper, stearic acid (SA) with good biocompatibility was innovatively added to increase the dispersion uniformity of SIM in the spinning solution, thus improving the performances of SIM-loaded PCL/PEG nanofiber membranes (NFMs). Accordingly, the effects of SA addition on the morphologies, mechanical properties, wettability, and drug release properties of the SIM-loaded NFMs were studied. The results showed that after SIM was dissolved in SA solution, the particle size of SIM was significantly reduced and could be evenly dispersed in the polymer spinning solution, thus obtaining the SIM-loaded composite NFMs with the best morphology and performance.     

壳聚糖-聚丙烯酸复合水凝胶的药物控制释放行为

以壳聚糖(Cs)和丙烯酸(AA)为原料,利用自由基聚合法制备了具有孔洞结构的复合水凝胶Cs-PAA,并研究了AA的量、交联剂的量、聚合温度和AA的中和度对水凝胶溶胀度的影响以及复合水凝胶对烟酸的控制释放。 结果表明,Cs-PAA复合水凝胶具有良好的pH值、离子强度敏感性,且溶胀度最高达1228 g/g,其在pH=686的缓冲溶液中的烟酸累积释放率明显大于其在pH=1.80的缓冲溶液,因此Cs-PAA水凝胶可作为肠口服药物的载体。